ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Clinical Evaluation of the Safety and Preliminary Efficacy of Continuous Infusion of Treprostinil to Prevent Ischemia and Reperfusion Injury in Adult Orthotopic Liver Transplant Recipients.

O. Almazroo,1 M. Miah,1 V. Pillai,1 A. Humar,2 A. Tevar,2 C. Hughes,2 A. AlKhafaji,3 A. Demetris,4 S. Dermont,2 S. Fedorek,2 H. Johnson,1 R. Lopez,2 R. Planinsic,2 B. Sengupta,2 I. Sethu,2 M. Sturdevant,2 S. Ziobert,1 R. Venkataramanan.1,2,4

1Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA
2Thomas Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA
3Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA
4Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA

Meeting: 2017 American Transplant Congress

Abstract number: 252

Keywords: Graft function, Ischemia, Liver transplantation, Survival

Session Information

Session Name: Concurrent Session: Liver Retransplantation and Other Complications

Session Type: Concurrent Session

Date: Monday, May 1, 2017

Session Time: 2:30pm-4:00pm

 Presentation Time: 3:30pm-3:42pm

Location: E353B

Introduction:

Liver transplantation is currently the only therapeutic option for patients with end stage liver diseases. Liver allografts undergo cold ischemic injury and warm reperfusion injury during preservation and transplantation procedure, respectively, which is known as ischemia reperfusion injury. We hypothesize that treprostinil, a stable prostacyclin analog, can be safely administered to the liver transplant patients who are hemodynamically stable, and predict that treprostinil will ameliorate ischemia reperfusion injury due to its vasodilatory and antiplatelet activity and ability to down-regulate pro-inflammatory cytokines.

Methods:

This study is a pilot single center, open-label, dose-escalation phase I/II study with outpatient follow-up for up to 180 days. Treprostinil was administered IV as a continuous infusion for 120 hrs after the patient is hemodynamically stable following the placement of new liver graft.

Results:

8 patients have completed the study and were dosed at 3 different infusion rates; 5 ng/kg/min for 48 hrs and 2.5 and 5 ng/kg/min for 120 hrs. Patients safety profile was documented by assessing: mPAP, CO, CI, HR, SBP and DBP. None of the hemodynamic parameters were affected by treprostinil and were within normal ranges. During the first 7 days after liver transplantation, total bilirubin, ALT and AST gradually reduced to normal levels in all patients. 95% of indocyanine green plasma disappearance rate values at day 2 and 5 of our patients were >18%/min (normal healthy subject value), indicating that treprostinil improved the hepatic uptake and hepatobiliary excretory capacity. All subjects and grafts survived throughout the study period (180 days).

Conclusion:

Our study shows that treprostinil can be safely given to liver transplant patients and appears to minimize hepatic ischemia and reperfusion injury.

CITATION INFORMATION: Almazroo O, Miah M, Pillai V, Humar A, Tevar A, Hughes C, AlKhafaji A, Demetris A, Dermont S, Fedorek S, Johnson H, Lopez R, Planinsic R, Sengupta B, Sethu I, Sturdevant M, Ziobert S, Venkataramanan R. Clinical Evaluation of the Safety and Preliminary Efficacy of Continuous Infusion of Treprostinil to Prevent Ischemia and Reperfusion Injury in Adult Orthotopic Liver Transplant Recipients. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Almazroo O, Miah M, Pillai V, Humar A, Tevar A, Hughes C, AlKhafaji A, Demetris A, Dermont S, Fedorek S, Johnson H, Lopez R, Planinsic R, Sengupta B, Sethu I, Sturdevant M, Ziobert S, Venkataramanan R. Clinical Evaluation of the Safety and Preliminary Efficacy of Continuous Infusion of Treprostinil to Prevent Ischemia and Reperfusion Injury in Adult Orthotopic Liver Transplant Recipients. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/clinical-evaluation-of-the-safety-and-preliminary-efficacy-of-continuous-infusion-of-treprostinil-to-prevent-ischemia-and-reperfusion-injury-in-adult-orthotopic-liver-transplant-recipients/. Accessed May 10, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences